Sign up Australia
Proactive Investors - Run By Investors For Investors

ResApp Health the leading ASX % Faller in morning trade on big volume

ResApp has traded over 90 mln shares by 11:30am this morning
The biggest % fallers on the ASX this morning

ResApp Health Ltd's (ASX:RAP) shares have plunged 76% to $0.074 in the first 90 minutes of trade after the company reported preliminary top-line results from the SMARTCOUGH-C Study.

The study is for the diagnosis of childhood respiratory disease using cough sounds.

Analysis of the SMARTCOUGH-C study data revealed many issues in the quality of cough recordings and that many patients were treated before their coughs were recorded.

ResApp intends to continue its Australian adult programme in parallel and initiate a US adult clinical study this US winter.

Company Name Code Last Change Volume
ResApp Health Ltd RAP $0.070 -77.42% 79,370,373
Jacka Resources Ltd JKA $0.003 -25% 22,600
Latin Resources Ltd LRS $0.004 -20% 3,423,002
Uranium Equities Ltd UEQ $0.005 -16.67% 610,000
Memphasys Ltd MEM $0.005 -16.67% 3,478,010
Eclipse Metals Ltd EPM $0.005 -16.67% 150,000
Hastings Technology Metals Ltd HAS $0.160 -15.79% 284,061
SportsHero Ltd SHO $0.032 -15.79% 50,000
Cohiba Mining CHK $0.011 -15.39% 1,750,880
Aruma Resources Ltd AAJ $0.006 -14.29% 120,000


Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

learning symbol on a keyboard
January 17 2017
The English language learning specialist is confident it can kick on in the coming year
Laptop screen with graphs
August 04 2017
Total revenues for the six months to 30 June grew by 5%, with Ebiquity adding it remains confident in hitting its operating profits and earnings targets for the rest of the year
picture of text
July 28 2017
Dotdigital ha been named as one of the fastest growing companies in Europe

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use